Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,506,251
-$5,051,468 QoQ
Shares Held
36,701
-56.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#196
of 594 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $99,390,670 across 8 Diagnostics & Research names. GH ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
136,482 | $23,708,288 | |
| 2 | WAT |
Waters Corp /De/
|
59,825 | $22,436,768 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
13,344 | $17,047,093 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
28,496 | $14,286,754 | |
| 5 | ILMN |
Illumina, Inc.
|
35,040 | $6,161,083 | |
| 6 | NTRA |
Natera, Inc.
|
22,077 | $5,992,801 | |
| 7 | GH |
Guardant Health, Inc.
This page
|
36,701 | $5,506,251 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
18,747 | $4,251,632 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,506,251 | 36,701 | Shares | Defined | 2026-08-14 | |
| 2021-09-30 | $10,557,719 | 84,455 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $46,463,328 | 374,131 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $31,193,111 | 204,344 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $29,368,658 | 227,876 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||